New Approval of Olaparib IndicationOn January 2nd, AstraZeneca and Merck jointly announced that their PARP inhibitor Lynparza® (Generic name: olaparib) has received approval for a new indication in China.
The topic of this report is a long-acting HIV "vaccine" called Lenacapavir, developed by Gilead Sciences in the United States.
We, Unibest, are excited to share with you the remarkable benefits and opportunities that Reteplase brings to the global market.
Unibest is proud to partner with a renowned Chinese Pharmaceutical company and announce the following global licensing opportunities:1.
Thrombolytic drugs play a crucial role in treating various venous and arterial thromboembolic conditions, particularly acute myocardial infarction.
Heparin is one of the oldest biological drugs used in treating thrombosis and hemostasis. It is a naturally occurring polysaccharide in the glycosaminoglycan (GAG) family, found primarily in mast cells.